Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Recruiting · NCT07719894 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes | Arterial Occlusive Diseases, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 4 | 2026-07-22 | NCT07719894 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Seoul National University Bundang Hospital | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 107 |